My Quote Request
6505-01-526-9930
20 Products
VT465
VISCOELASTIC,DISPER
NSN, MFG P/N
6505015269930
NSN
6505-01-526-9930
MFG
ADVANCED MEDICAL OPTICS INC. DBA A M O
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 3 PERCENT SODIUM HYALURONATE DISPERSIVE VISCOELSTIC SOLUTION;LOW MOLECULAR WEIGHT PROVIDING PROTECTION AND VISCOSITY DURING PHACOEMULSIFICATION ANDSMALL INCISION SURGERY;CAN BE USED DURNING CORNEAL TRANSPLANTATION SURGERY AND GLAUCOMA FILTERING SURGERY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VITRAX II OPTHALMIC
Related Searches:
04-1603
RIMANTADINE HYDROCH
NSN, MFG P/N
6505015265589
NSN
6505-01-526-5589
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RIMANTADINE HYDROCHLORIDE TABLET FLUMADINE 100MG 100 TBS
III SUPPLEMENTARY FEATURES: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION: 081804
SPECIAL FEATURES: 100MG OF RIMANTADINE HCL; 100 TABS PER BOTTLE; FILM COATED; AN ANTIVIRAL AGENT USED TO PREVENT AND TREAT INFLUENZA A VIRUS; STORE AT ROOM TEMPERATURE (59-86 DEG F) IN A TIGHTLY-CLOSED CONTAINER, AWAY FROM HEAT AND LIGHT
Related Searches:
FLUMADINE
RIMANTADINE HYDROCH
NSN, MFG P/N
6505015265589
NSN
6505-01-526-5589
MFG
FOREST LABORATORIES INC. DIV INWOOD LABORATORIES
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RIMANTADINE HYDROCHLORIDE TABLET FLUMADINE 100MG 100 TBS
III SUPPLEMENTARY FEATURES: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION: 081804
SPECIAL FEATURES: 100MG OF RIMANTADINE HCL; 100 TABS PER BOTTLE; FILM COATED; AN ANTIVIRAL AGENT USED TO PREVENT AND TREAT INFLUENZA A VIRUS; STORE AT ROOM TEMPERATURE (59-86 DEG F) IN A TIGHTLY-CLOSED CONTAINER, AWAY FROM HEAT AND LIGHT
Related Searches:
NDC00258-3711-01
RIMANTADINE HYDROCH
NSN, MFG P/N
6505015265589
NSN
6505-01-526-5589
MFG
FOREST LABORATORIES INC. DIV INWOOD LABORATORIES
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RIMANTADINE HYDROCHLORIDE TABLET FLUMADINE 100MG 100 TBS
III SUPPLEMENTARY FEATURES: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION: 081804
SPECIAL FEATURES: 100MG OF RIMANTADINE HCL; 100 TABS PER BOTTLE; FILM COATED; AN ANTIVIRAL AGENT USED TO PREVENT AND TREAT INFLUENZA A VIRUS; STORE AT ROOM TEMPERATURE (59-86 DEG F) IN A TIGHTLY-CLOSED CONTAINER, AWAY FROM HEAT AND LIGHT
Related Searches:
04-1606
PENTETATE CALCIUM T
NSN, MFG P/N
6505015266210
NSN
6505-01-526-6210
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENTETATE CALCIUM TRISODIUM INJ. CA-DTPA 5ML AMPOULES 10S
III SUPPLEMENTARY FEATURES: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 640000
SPECIAL FEATURES: EACH AMPULE CONTAINS THE EQUIV. OF 1,000 MG OF PENTETATE CALCIUM TRISODIUM; A STERILE SOLUTION IN 5ML SINGLE USE CLEAR GLASS AMPOULES, A CONCENTRATION OF 200 MG/ML FOR IV USE; 10 5ML SINGLE USE AMPOULES PER PKG; STORE BETWEEN 15-30 DEG C; INDICATED FOR
~1: TREATMENT OF INDIVIDUALS WITH KNOWN OR SUSPECTED INTERNAL CONTAMINATION WITH PLUTONIUM,AMERICIUM OR CURIUM TO INCREASE THE RATES OF ELIMINATION; INITIAL DOSE: ADULTS AND ADOLESCENTS, A SINGLE 1.0 AMP. INTITIAL
Related Searches:
CA-DTPA
PENTETATE CALCIUM T
NSN, MFG P/N
6505015266210
NSN
6505-01-526-6210
MFG
AKORN INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENTETATE CALCIUM TRISODIUM INJ. CA-DTPA 5ML AMPOULES 10S
III SUPPLEMENTARY FEATURES: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 640000
SPECIAL FEATURES: EACH AMPULE CONTAINS THE EQUIV. OF 1,000 MG OF PENTETATE CALCIUM TRISODIUM; A STERILE SOLUTION IN 5ML SINGLE USE CLEAR GLASS AMPOULES, A CONCENTRATION OF 200 MG/ML FOR IV USE; 10 5ML SINGLE USE AMPOULES PER PKG; STORE BETWEEN 15-30 DEG C; INDICATED FOR
~1: TREATMENT OF INDIVIDUALS WITH KNOWN OR SUSPECTED INTERNAL CONTAMINATION WITH PLUTONIUM,AMERICIUM OR CURIUM TO INCREASE THE RATES OF ELIMINATION; INITIAL DOSE: ADULTS AND ADOLESCENTS, A SINGLE 1.0 AMP. INTITIAL
Related Searches:
NDC52919-0001-03
PENTETATE CALCIUM T
NSN, MFG P/N
6505015266210
NSN
6505-01-526-6210
MFG
AKORN INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENTETATE CALCIUM TRISODIUM INJ. CA-DTPA 5ML AMPOULES 10S
III SUPPLEMENTARY FEATURES: AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 640000
SPECIAL FEATURES: EACH AMPULE CONTAINS THE EQUIV. OF 1,000 MG OF PENTETATE CALCIUM TRISODIUM; A STERILE SOLUTION IN 5ML SINGLE USE CLEAR GLASS AMPOULES, A CONCENTRATION OF 200 MG/ML FOR IV USE; 10 5ML SINGLE USE AMPOULES PER PKG; STORE BETWEEN 15-30 DEG C; INDICATED FOR
~1: TREATMENT OF INDIVIDUALS WITH KNOWN OR SUSPECTED INTERNAL CONTAMINATION WITH PLUTONIUM,AMERICIUM OR CURIUM TO INCREASE THE RATES OF ELIMINATION; INITIAL DOSE: ADULTS AND ADOLESCENTS, A SINGLE 1.0 AMP. INTITIAL
Related Searches:
04-1607
PENTETATE ZINC TRIS
NSN, MFG P/N
6505015266547
NSN
6505-01-526-6547
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENTETATE ZINC TRISODIUM INJ ZN-DTPA 5ML AMPOULE 10S
III SUPPLEMENTARY FEATURES: AMERICAN HOSPITAL FORMULARY SERVICE CALSSIFICATION NUMBER: 640000
SPECIAL FEATURES: EACH AMPOULE CONTAINS THE EQUIV. OF 1,000 MG. PENTETATE ZINC TRISODIUM; A CONCENTRATION OF 200 MG/ML FOR IV USE; A STERILE SOLUTION IN 5ML SINGLE-USE CLEAR GLASS AMPOULES; PKG. OF 10; STORE BETWEEN 15-30 DEG.C; INDICATED FOR TREATMENT OF INDIVIDUALS WITH
~1: KNOWN OR SUSPECTED INTERNAL CONTAMINATION WITH PLUTONIUM, AMERICIUM OR CURIUM, TO INCREASE THE RATES OF ELIMINATION; ADULTS AND ADOLESCENTS A SINGLE 1.0 GRAM INITIAL DOSE
Related Searches:
NDC52919-0002-03
PENTETATE ZINC TRIS
NSN, MFG P/N
6505015266547
NSN
6505-01-526-6547
MFG
AKORN INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENTETATE ZINC TRISODIUM INJ ZN-DTPA 5ML AMPOULE 10S
III SUPPLEMENTARY FEATURES: AMERICAN HOSPITAL FORMULARY SERVICE CALSSIFICATION NUMBER: 640000
SPECIAL FEATURES: EACH AMPOULE CONTAINS THE EQUIV. OF 1,000 MG. PENTETATE ZINC TRISODIUM; A CONCENTRATION OF 200 MG/ML FOR IV USE; A STERILE SOLUTION IN 5ML SINGLE-USE CLEAR GLASS AMPOULES; PKG. OF 10; STORE BETWEEN 15-30 DEG.C; INDICATED FOR TREATMENT OF INDIVIDUALS WITH
~1: KNOWN OR SUSPECTED INTERNAL CONTAMINATION WITH PLUTONIUM, AMERICIUM OR CURIUM, TO INCREASE THE RATES OF ELIMINATION; ADULTS AND ADOLESCENTS A SINGLE 1.0 GRAM INITIAL DOSE
Related Searches:
ZN-DTPA
PENTETATE ZINC TRIS
NSN, MFG P/N
6505015266547
NSN
6505-01-526-6547
MFG
AKORN INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENTETATE ZINC TRISODIUM INJ ZN-DTPA 5ML AMPOULE 10S
III SUPPLEMENTARY FEATURES: AMERICAN HOSPITAL FORMULARY SERVICE CALSSIFICATION NUMBER: 640000
SPECIAL FEATURES: EACH AMPOULE CONTAINS THE EQUIV. OF 1,000 MG. PENTETATE ZINC TRISODIUM; A CONCENTRATION OF 200 MG/ML FOR IV USE; A STERILE SOLUTION IN 5ML SINGLE-USE CLEAR GLASS AMPOULES; PKG. OF 10; STORE BETWEEN 15-30 DEG.C; INDICATED FOR TREATMENT OF INDIVIDUALS WITH
~1: KNOWN OR SUSPECTED INTERNAL CONTAMINATION WITH PLUTONIUM, AMERICIUM OR CURIUM, TO INCREASE THE RATES OF ELIMINATION; ADULTS AND ADOLESCENTS A SINGLE 1.0 GRAM INITIAL DOSE
Related Searches:
04-1658
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267900
NSN
6505-01-526-7900
04-1658
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267900
NSN
6505-01-526-7900
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACD SOLUTION USP FORMULA A 1000ML IN PL146 PLASTIC CONTAINER 12S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: ACD SOLUTION, USP, FORMULA A, 1000ML, IN PL146 PLASTIC CONTAINER, FOR USE WITH CYTAPHERESIS DEVICES; 12 PER CASE
Related Searches:
4B7891
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267900
NSN
6505-01-526-7900
4B7891
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267900
NSN
6505-01-526-7900
MFG
BAXTER HEALTHCARE CORPORATION DIV BIOSCIENCE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACD SOLUTION USP FORMULA A 1000ML IN PL146 PLASTIC CONTAINER 12S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: ACD SOLUTION, USP, FORMULA A, 1000ML, IN PL146 PLASTIC CONTAINER, FOR USE WITH CYTAPHERESIS DEVICES; 12 PER CASE
Related Searches:
6505NCM050011
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267900
NSN
6505-01-526-7900
6505NCM050011
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267900
NSN
6505-01-526-7900
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACD SOLUTION USP FORMULA A 1000ML IN PL146 PLASTIC CONTAINER 12S
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: ACD SOLUTION, USP, FORMULA A, 1000ML, IN PL146 PLASTIC CONTAINER, FOR USE WITH CYTAPHERESIS DEVICES; 12 PER CASE
Related Searches:
04-1657
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267904
NSN
6505-01-526-7904
04-1657
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267904
NSN
6505-01-526-7904
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACD SOLUTION USP FORMULA A 500ML IN PL146 PLASTIC CONTAINER 24S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: ACD SOLUTION, USP, FORMULA A, 500ML, IN PL146 PLASTIC CONTAINER, FOR USE WITH CYTAPHERESIS DEVICES; 24 PER CASE
Related Searches:
4B7898Q
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267904
NSN
6505-01-526-7904
4B7898Q
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267904
NSN
6505-01-526-7904
MFG
BAXTER HEALTHCARE CORPORATION DIV BIOSCIENCE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACD SOLUTION USP FORMULA A 500ML IN PL146 PLASTIC CONTAINER 24S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: ACD SOLUTION, USP, FORMULA A, 500ML, IN PL146 PLASTIC CONTAINER, FOR USE WITH CYTAPHERESIS DEVICES; 24 PER CASE
Related Searches:
6505NCM050010
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267904
NSN
6505-01-526-7904
6505NCM050010
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267904
NSN
6505-01-526-7904
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACD SOLUTION USP FORMULA A 500ML IN PL146 PLASTIC CONTAINER 24S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: ACD SOLUTION, USP, FORMULA A, 500ML, IN PL146 PLASTIC CONTAINER, FOR USE WITH CYTAPHERESIS DEVICES; 24 PER CASE
Related Searches:
ACD SOLUTION
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267904
NSN
6505-01-526-7904
ACD SOLUTION
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505015267904
NSN
6505-01-526-7904
MFG
BAXTER HEALTHCARE CORPORATION DIV BIOSCIENCE
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ACD SOLUTION USP FORMULA A 500ML IN PL146 PLASTIC CONTAINER 24S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: ACD SOLUTION, USP, FORMULA A, 500ML, IN PL146 PLASTIC CONTAINER, FOR USE WITH CYTAPHERESIS DEVICES; 24 PER CASE
Related Searches:
04-1665
TETANUS AND DIPHTHERIA TOXOIDS FOR ADULT USE,ADSORBED,USP
NSN, MFG P/N
6505015267958
NSN
6505-01-526-7958
04-1665
TETANUS AND DIPHTHERIA TOXOIDS FOR ADULT USE,ADSORBED,USP
NSN, MFG P/N
6505015267958
NSN
6505-01-526-7958
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 808000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TETANUS AND DIPHTHERIA TOXOIDS ADSORBED FOR ADULT USE INTRAMUSCULAR INJECTION 0.5ML SYRINGE UNIT DOSE 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING AND REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C
III SUPPLEMENTARY FEATURES: FOR INTRAMUSCULAR INJECTION; PREFILLED LUER-LOK LATEX-FREE SYRINGES
IMMEDIATE CONTAINER QUANTITY: 10
IMMEDIATE CONTAINER TYPE: SYRINGE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 0.5ML
SPECIAL FEATURES: A STERILE SUSPENSION OF ALUM-PRECIPITATED (ALUMINUM POTASSIUM SULFATE) TOXOIDS IN AN ISOTONIC SODIUM CHLORIDE SOLUTION; SUPPLIED IN UNIT DOSE 0.5ML PRESERVATIVE-FREE PREFILLED SYRINGE BUT CONTAINS A TRACE AMOUNT OF THIMEROSAL; EACH 0.5ML DOSE IS
UNIT PACKAGE TYPE: PACKAGE
~1: FORMULATED TO CONTAIN 5 LF OF TETANUS TOXOID, 2LF OF DIPHTHERIA TOXOID AND NOT MORE THAN 0.28 MG OF ALUMINUM BY ASSAY; DO NOT ADMINISTER INTRAVENOUSLY OR SUBCUTANEOUSLY; FOR IMMUNIZATION OF PERSONS 7 YRS OF AGE AND OLDER FOR PREVENTION OF TETANUS AND
~2: DIPHTHERIA
Related Searches:
DECAVAC
TETANUS AND DIPHTHERIA TOXOIDS FOR ADULT USE,ADSORBED,USP
NSN, MFG P/N
6505015267958
NSN
6505-01-526-7958
DECAVAC
TETANUS AND DIPHTHERIA TOXOIDS FOR ADULT USE,ADSORBED,USP
NSN, MFG P/N
6505015267958
NSN
6505-01-526-7958
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 808000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TETANUS AND DIPHTHERIA TOXOIDS ADSORBED FOR ADULT USE INTRAMUSCULAR INJECTION 0.5ML SYRINGE UNIT DOSE 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING AND REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C
III SUPPLEMENTARY FEATURES: FOR INTRAMUSCULAR INJECTION; PREFILLED LUER-LOK LATEX-FREE SYRINGES
IMMEDIATE CONTAINER QUANTITY: 10
IMMEDIATE CONTAINER TYPE: SYRINGE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 0.5ML
SPECIAL FEATURES: A STERILE SUSPENSION OF ALUM-PRECIPITATED (ALUMINUM POTASSIUM SULFATE) TOXOIDS IN AN ISOTONIC SODIUM CHLORIDE SOLUTION; SUPPLIED IN UNIT DOSE 0.5ML PRESERVATIVE-FREE PREFILLED SYRINGE BUT CONTAINS A TRACE AMOUNT OF THIMEROSAL; EACH 0.5ML DOSE IS
UNIT PACKAGE TYPE: PACKAGE
~1: FORMULATED TO CONTAIN 5 LF OF TETANUS TOXOID, 2LF OF DIPHTHERIA TOXOID AND NOT MORE THAN 0.28 MG OF ALUMINUM BY ASSAY; DO NOT ADMINISTER INTRAVENOUSLY OR SUBCUTANEOUSLY; FOR IMMUNIZATION OF PERSONS 7 YRS OF AGE AND OLDER FOR PREVENTION OF TETANUS AND
~2: DIPHTHERIA
Related Searches:
NDC49281-0291-10
TETANUS AND DIPHTHERIA TOXOIDS FOR ADULT USE,ADSORBED,USP
NSN, MFG P/N
6505015267958
NSN
6505-01-526-7958
NDC49281-0291-10
TETANUS AND DIPHTHERIA TOXOIDS FOR ADULT USE,ADSORBED,USP
NSN, MFG P/N
6505015267958
NSN
6505-01-526-7958
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 808000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TETANUS AND DIPHTHERIA TOXOIDS ADSORBED FOR ADULT USE INTRAMUSCULAR INJECTION 0.5ML SYRINGE UNIT DOSE 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING AND REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C
III SUPPLEMENTARY FEATURES: FOR INTRAMUSCULAR INJECTION; PREFILLED LUER-LOK LATEX-FREE SYRINGES
IMMEDIATE CONTAINER QUANTITY: 10
IMMEDIATE CONTAINER TYPE: SYRINGE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 0.5ML
SPECIAL FEATURES: A STERILE SUSPENSION OF ALUM-PRECIPITATED (ALUMINUM POTASSIUM SULFATE) TOXOIDS IN AN ISOTONIC SODIUM CHLORIDE SOLUTION; SUPPLIED IN UNIT DOSE 0.5ML PRESERVATIVE-FREE PREFILLED SYRINGE BUT CONTAINS A TRACE AMOUNT OF THIMEROSAL; EACH 0.5ML DOSE IS
UNIT PACKAGE TYPE: PACKAGE
~1: FORMULATED TO CONTAIN 5 LF OF TETANUS TOXOID, 2LF OF DIPHTHERIA TOXOID AND NOT MORE THAN 0.28 MG OF ALUMINUM BY ASSAY; DO NOT ADMINISTER INTRAVENOUSLY OR SUBCUTANEOUSLY; FOR IMMUNIZATION OF PERSONS 7 YRS OF AGE AND OLDER FOR PREVENTION OF TETANUS AND
~2: DIPHTHERIA